ChiCTR2200057403 版本V1.2 版本创建时间2022/11/10 17:48:24 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200057403 

最近更新日期:

Date of Last Refreshed on:

2022-11-01 12:08:30 

注册时间:

Date of Registration:

2022-03-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于增强CT影像组学的急性胰腺炎炎症活跃程度研究

Public title:

Study of inflammatory activity in acute pancreatitis based on enhanced CT imaging

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于增强CT影像组学的急性胰腺炎炎症活跃程度研究

Scientific title:

Study of inflammatory activity in acute pancreatitis based on enhanced CT imaging

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

余柠君 

研究负责人:

张小明 

Applicant:

Ningjun, Yu 

Study leader:

Xiaoming, Zhang 

申请注册联系人电话:

Applicant telephone:

15183080217

研究负责人电话:

Study leader's
telephone:

13808271001

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

379401799@qq.com

研究负责人电子邮件:

Study leader's E-mail:

cjr.zhxm@vip.163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省南充市顺庆区涪江路234号

研究负责人通讯地址:

四川省南充市顺庆区涪江路234号

Applicant address:

234 Fujiang Road, Shunqing, Nanchong, Sichuan

Study leader's address:

234 Fujiang Road, Shunqing, Nanchong, Sichuan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

川北医学院附属医院

Applicant's institution:

Affiliated Hospital of North Sichuan Medical College

研究负责人所在单位:

川北医学院附属医院

Affiliation of the Leader:

Affiliated Hospital of North Sichuan Medical College

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021ER166-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

川北医学院附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Affiliated Hospital of North Sichuan Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

2021-11-17 00:00:00

伦理委员会联系人:

李娟

Contact Name of the ethic committee:

Juan li

伦理委员会联系地址:

四川省南充市顺庆区茂源南路1号

Contact Address of the ethic committee:

1 South Maoyuan Road, Shunqing, Nanchong, Sichuan

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

川北医学院附属医院

Primary sponsor:

Affiliated Hospital of North Sichuan Medical College

研究实施负责(组长)单位地址:

四川省南充市顺庆区茂源南路1号

Primary sponsor's address:

1 South Maoyuan Road, Shunqing, Nanchong, Sichuan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

南充

Country:

China

Province:

Sichuan

City:

Nanchong

单位(医院):

川北医学院附属医院

具体地址:

四川省南充市顺庆区茂源南路1号

Institution
hospital:

Affiliated Hospital of North Sichuan Medical College

Address:

1 South Maoyuan Road, Shunqing, Nanchong, Sichuan

经费或物资来源:

-

Source(s) of funding:

-

研究疾病:

急性胰腺炎  

Target disease:

acute pancreatitis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

诊断性病例对照试验 

Study design:

Diagnostic test: case-control 

研究目的:

观察影像组学判断急性胰腺炎炎症活跃程度的诊断价值  

Objectives of Study:

To evaluate the diagnostic value of radiometrics in acute pancreatitis

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)急性胰腺炎的诊断标准符合2012年修改版急性胰腺炎亚特兰大分类;(2)住院期间行腹部CT/MRI增强检查的患者;(3)在上述放射检查3天内,有相关实验室检查资料、病历的患者。

Inclusion criteria

(1)The diagnostic criteria were in line with the 2012 modified Atlanta Classification of acute pancreatitis;(2)Abdominal CT enhancement was performed during hospitalization;(3)Relevant laboratory examination data and medical records are available within 3 days of examination.

排除标准:

(1)慢性胰腺炎急性发作;(2)胰腺肿瘤所致急性胰腺炎;(3)合并癌症、严重慢性消耗性疾病和其他遗传性疾病的;(4)图像不满意或病历不完整。(5)患者年龄小于18岁或者为孕妇。

Exclusion criteria:

(1) acute attack of chronic pancreatitis; (2) acute pancreatitis caused by pancreatic tumor; (3) complicated with cancer, severe (1) acute attack of chronic pancreatitis; (2) acute pancreatitis caused by pancreatic tumor; (3) complicated with cancer, severe chronic wasting diseases or other hereditary diseases; (4) Unsatisfactory images or incomplete medical records. (5) The patient is younger than 18 years old or pregnant. Serious chronic wasting diseases and other hereditary diseases; (4) Unsatisfactory images or incomplete medical records. (5) The patient is younger than 18 years old or pregnant.

研究实施时间:

Study execute time:

From 2022-05-01 00:00:00 To 2023-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-05-01 00:00:00 To 2023-11-30 00:00:00

干预措施:

Interventions:

组别:

1

样本量:

400

Group:

1

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

南充 

Country:

China

Province:

Sichuan

City:

Nanchong

单位(医院):

川北医学院附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of North Sichuan Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

影像组学特征

指标类型:

主要指标

Outcome:

radiomics features

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 100 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

-

Randomization Procedure (please state who generates the random number sequence and by what method):

-

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

-

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

-

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

-

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

-

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-03-11 15:20:49